• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于研究良性人体肿瘤的患者来源异种移植模型。

Patient-derived xenograft models for the study of benign human neoplasms.

机构信息

Department of Pathology, Biological Science Institute (ICB), Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil.

Department of Oral Surgery and Pathology, School of Dentistry, Universidade Federal de Minas Gerais (UFMG), Belo Horizonte, Brazil..

出版信息

Exp Mol Pathol. 2021 Jun;120:104630. doi: 10.1016/j.yexmp.2021.104630. Epub 2021 Mar 17.

DOI:10.1016/j.yexmp.2021.104630
PMID:33744281
Abstract

Preclinical models are a core feature of translational research, and patient-derived xenograft (PDX) models have increasingly been used with such purpose. PDX involves the transplantation of fresh human tumor samples into immunodeficient mice to overcome immunologic rejection. It is a valuable tool for basic as well as preclinical research, contributing to the establishment of models to characterize the neoplasms to drug screening and to allow the identification of therapeutic targets. The use of these models is justified because they retain the histological and genomic features of the primary tumor. PDX models are well described for malignant neoplasms, for which the advantages are clear and include the development of drug treatments. The establishment of malignant tumors PDX is undeniably important from a medical perspective. However, few studies have used such models for benign neoplasms. The use of PDX for benign neoplasm studies can help to clarify the pathobiology of these diseases, as well as invasion and malignant transformation mechanisms, which from a biological perspective is equally important to the study of malignant tumors. Therefore, the aim of this study is to review the current methodology for PDX model generation and to cover its main applications, focusing on benign neoplasms.

摘要

临床前模型是转化研究的核心特征,并且越来越多地使用患者来源的异种移植(PDX)模型来实现这一目的。PDX 涉及将新鲜的人类肿瘤样本移植到免疫缺陷小鼠中,以克服免疫排斥。它是基础研究和临床前研究的有价值的工具,有助于建立模型来对肿瘤进行特征描述、进行药物筛选,并确定治疗靶点。使用这些模型是合理的,因为它们保留了原发性肿瘤的组织学和基因组特征。PDX 模型在恶性肿瘤中得到了很好的描述,其优势是明确的,包括开发药物治疗。从医学角度来看,建立恶性肿瘤 PDX 模型无疑是重要的。然而,很少有研究使用这些模型来研究良性肿瘤。使用 PDX 研究良性肿瘤有助于阐明这些疾病的病理生物学,以及侵袭和恶性转化机制,从生物学角度来看,这与恶性肿瘤的研究同样重要。因此,本研究旨在综述 PDX 模型生成的当前方法学,并涵盖其主要应用,重点是良性肿瘤。

相似文献

1
Patient-derived xenograft models for the study of benign human neoplasms.用于研究良性人体肿瘤的患者来源异种移植模型。
Exp Mol Pathol. 2021 Jun;120:104630. doi: 10.1016/j.yexmp.2021.104630. Epub 2021 Mar 17.
2
Patient-derived tumor xenografts: transforming clinical samples into mouse models.患者来源的肿瘤异种移植物:将临床样本转化为小鼠模型。
Cancer Res. 2013 Sep 1;73(17):5315-9. doi: 10.1158/0008-5472.CAN-13-1069. Epub 2013 Jun 3.
3
Patient-Derived Xenograft Establishment from Human Malignant Pleural Mesothelioma.患者来源的人恶性胸膜间皮瘤异种移植的建立。
Clin Cancer Res. 2017 Feb 15;23(4):1060-1067. doi: 10.1158/1078-0432.CCR-16-0844. Epub 2016 Sep 28.
4
The fidelity of cancer cells in PDX models: Characteristics, mechanism and clinical significance.PDX 模型中癌细胞的保真度:特征、机制和临床意义。
Int J Cancer. 2020 Apr 15;146(8):2078-2088. doi: 10.1002/ijc.32662. Epub 2019 Nov 6.
5
Establishment of a patient-derived xenograft model and cell line of malignant transformation of mature cystic teratoma of the ovary.卵巢成熟囊性畸胎瘤恶性转化的患者来源异种移植模型和细胞系的建立。
J Obstet Gynaecol Res. 2021 Feb;47(2):713-719. doi: 10.1111/jog.14596. Epub 2020 Dec 9.
6
The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.患者来源异种移植模型在癌症研究中的产生与应用。
Cancer Res Treat. 2018 Jan;50(1):1-10. doi: 10.4143/crt.2017.307. Epub 2017 Sep 13.
7
Applications of patient-derived tumor xenograft models and tumor organoids.患者来源肿瘤异种移植模型和肿瘤类器官的应用。
J Hematol Oncol. 2020 Jan 7;13(1):4. doi: 10.1186/s13045-019-0829-z.
8
Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.肝细胞癌和转移性肝癌患者来源异种移植模型的综合比较。
Int J Med Sci. 2020 Oct 22;17(18):3073-3081. doi: 10.7150/ijms.46686. eCollection 2020.
9
Lymphoma transformation of tumor infiltrating lymphocytes observed in testicular patient‑derived xenograft models.在睾丸患者来源异种移植模型中观察到肿瘤浸润淋巴细胞的淋巴瘤转化。
Oncol Rep. 2018 Dec;40(6):3593-3602. doi: 10.3892/or.2018.6769. Epub 2018 Oct 5.
10
Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.捕获患者来源异种移植(PDX)模型中的结直肠癌肿瘤间异质性。
Int J Cancer. 2019 Jan 15;144(2):366-371. doi: 10.1002/ijc.31767. Epub 2018 Oct 22.

引用本文的文献

1
Organoids: approaches and utility in cancer research.类器官:在癌症研究中的方法和应用。
Chin Med J (Engl). 2023 Aug 5;136(15):1783-1793. doi: 10.1097/CM9.0000000000002477.
2
Angiogenesis in patient-derived xenografts of odontogenic myxoma.牙源性黏液瘤患者来源异种移植物中的血管生成。
Int J Exp Pathol. 2022 Apr;103(2):65-69. doi: 10.1111/iep.12431. Epub 2022 Feb 28.